Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients

Cellular Oncology

Volumn 34, Issue 5, 2011, Pages 435-441

  Muscarella, Lucia Anna ^a   D'Alessandro, Vito ^a   Torre, Annamaria La ^a   Copetti, Massimiliano ^a   De Cata, Angelo ^a   Parrella, Paola ^a,b   Sperandeo, Marco ^a   Pellegrini, Fabio ^a   Frusciante, Vincenzo ^a   Maiello, Evaristo ^a   Merla, Giuseppe ^a   Fazio, Vito Michele ^a   Vendemiale, Gianluigi ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

Neuroendocrine lung cancer; Real time quantitative PCR; SSTRs

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PENTETREOTIDE IN 111; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 5; YTTRIUM 90; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; TUMOR MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE DOSAGE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG CARCINOID; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN RECEPTOR 2A GENE; SOMATOSTATIN RECEPTOR 3 GENE; SOMATOSTATIN RECEPTOR 5 GENE; STATISTICAL SIGNIFICANCE; BLOOD; CANCER STAGING; CASE CONTROL STUDY; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; NEUROENDOCRINE TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84860570657     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0025-9     Document Type: Article

References (21)

1. A.V. Schally, Oncological applications of somatostatin analogues. Cancer Res. 48, 6977-6985 (1988)
2. C. Capella, P.U. Heitz, H. Höfler, E. Solcia, G. Klöppel, Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 6, 547-560 (1995)
3. V.E. Gould, W. Jao, G. Chejfec, B.F. Banner, P. Bonomi, Neuroendocrine carcinomas of the gastrointestinal tract. Semin. Diagn. Pathol. 1, 13-18 (1984)
4. K. Oberg, B. Eriksson, E.T. Janson, The clinical use of interferons in the management of neuroendocrine gastroenteropancreatic tumors. Ann. NY Acad. Sci. 15, 471-478 (1994)
5. N. Kimura, W. Miura, T. Noshiro, Y. Miura, T. Ookuma, H. Nagura, Ki67 is an indicator of progression of neuroendocrine tumors. Endocr. Pathol. 5, 223-228 (1994)
6. C. Bruns, G. Weckbecker, F. Raulf, K. Kaupmann, P. Schoeffter, D. Hoyer, H. Lübbert, Molecular pharmacology of somatostatinreceptor subtypes. Ann. NY Acad. Sci. 15, 138-146 (1994)
7. Y.C. Patel, C.B. Srikant, Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135, 2814-2817 (1994)
8. V. D'Alessandro, L.A. Muscarella, M. Copetti, L. Zelante, M. Carella, G. Vendemiale, Molecular detection of neuron-specific ELAV-like-positive cells in the peripheral blood of patients with small-cell lung cancer. Cell. Oncol. 30, 291-297 (2008)
9. K. Swerts, B. De Moerloose, C. Dhooge, J. Vandesompele, C. Hoyoux, K. Beiske, Y. Benoit, G. Laureys, J. Philippe, Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells. Clin. Chem. 52, 438-445 (2006)
10. P. Goldstraw (ed.), IASLC staging manual in thoracic oncology (Editorial Rx Press, Orange Park, 2009)
11. M. Pless, C. Waldherr, H. Maecke, C. Buitrago, R. Herrmann, J. Mueller-Brand, Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial. Lung Cancer 45, 365-371 (2004)
12. G.F. Taboada, R.M. Luque, W. Bastos, R.F. Guimarães, J.B. Marcondes, L.M. Chimelli, R. Fontes, P.J. Mata, P.N. Filho, D.P. Carvalho, R.D. Kineman, M.R. Gadelha, Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas. Eur. J. Endocrinol. 156, 65-74 (2007)
13. M. de Jong, W.A. Breeman, D.J. Kwekkeboom, R. Valkema, E.P. Krenning, Tumor imaging and therapy using radiolabeled somatostatin analogues. Acc. Chem. Res. 42(7), 873-880 (2009)
14. N. Kimura, M. Pilichowska, F. Date, I. Kimura, M. Schindler, Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin. Cancer Res. 5, 3483-3487 (1999)
15. H. Pisarek, T. Stepień, R. Kubiak, E. Borkowska, M. Pawlikowski, Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation. Thyroid Res. 27, 1 (2009)
16. L. Righi, M. Volante, V. Tavaglione, A. Billè, L. Daniele, T. Angusti, F. Inzani, G. Pelosi, G. Rindi, M. Papotti, Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. Ann. Oncol. 21, 548-555 (2010)
17. G.F. Taboada, R.M. Luque, L.V. Neto, O. Machado Ede, B.C. Sbaffi, R.C. Domingues, J.B. Marcondes, L.M. Chimelli, R. Fontes, P. Niemeyer, D.P. de Carvalho, R.D. Kineman, M.R. Gadelha, Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR. Eur J Endocrinol 158, 295-303 (2008)
18. M. Papotti, S. Croce, M. Bellò, M. Bongiovanni, E. Allìa, M. Schindler, G. Bussolati, Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy. Virchows Arch. 439, 787-797 (2001)
19. A. Schoenfeld, K.H. Kruger, J. Gomm, H.D. Sinnett, J.-C. Gazet, N. Sacks, H.G. Bender, Y. Luqmani, R.C. Coombes, The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistoChemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur. J. Cancer 33, 854-861 (1997)
20. R. Schuster, N. Max, B. Mann, K. Heufelder, F. Thilo, J. Gröne, F. Rokos, H.-J. Buhr, E. Thiel, U. Keilholz, Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int. J. Cancer 108(2), 219-227 (2004)
21. A. Stathopoulou, I. Vlachonikolis, D. Mavroudis, M. Perraki, Ch Kouroussis, S. Apostolaki, N. Malamos, S. Kakolyris, A. Kotsakis, N. Xenidis, D. Reppa, V. Georgoulias, Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J. Clin. Oncol. 20(16), 3404-3412 (2002)